» Articles » PMID: 17134490

Interleukin-4 Induction of the CC Chemokine TARC (CCL17) in Murine Macrophages is Mediated by Multiple STAT6 Sites in the TARC Gene Promoter

Overview
Journal BMC Mol Biol
Publisher Biomed Central
Specialty Molecular Biology
Date 2006 Dec 1
PMID 17134490
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Macrophages (Mtheta) play a central role in the innate immune response and in the pathology of chronic inflammatory diseases. Macrophages treated with Th2-type cytokines such as Interleukin-4 (IL-4) and Interleukin-13 (IL-13) exhibit an altered phenotype and such alternatively activated macrophages are important in the pathology of diseases characterised by allergic inflammation including asthma and atopic dermatitis. The CC chemokine Thymus and Activation-Regulated Chemokine (TARC/CCL17) and its murine homologue (mTARC/ABCD-2) bind to the chemokine receptor CCR4, and direct T-cell and macrophage recruitment into areas of allergic inflammation. Delineating the molecular mechanisms responsible for the IL-4 induction of TARC expression will be important for a better understanding of the role of Th2 cytokines in allergic disease.

Results: We demonstrate that mTARC mRNA and protein are potently induced by the Th2 cytokine, Interleukin-4 (IL-4), and inhibited by Interferon-gamma (IFN-gamma) in primary macrophages (Mtheta). IL-4 induction of mTARC occurs in the presence of PI3 kinase pathway and translation inhibitors, but not in the absence of STAT6 transcription factor, suggesting a direct-acting STAT6-mediated pathway of mTARC transcriptional activation. We have functionally characterised eleven putative STAT6 sites identified in the mTARC proximal promoter and determined that five of these contribute to the IL-4 induction of mTARC. By in vitro binding assays and transient transfection of isolated sites into the RAW 264.7 Mtheta cell-line, we demonstrate that these sites have widely different capacities for binding and activation by STAT6. Site-directed mutagenesis of these sites within the context of the mTARC proximal promoter revealed that the two most proximal sites, conserved between the human and mouse genes, are important mediators of the IL-4 response.

Conclusion: The induction of mTARC by IL-4 results from cooperative interactions between STAT6 sites within the mTARC gene promoter. Significantly, we have shown that transfer of the nine most proximal mTARC STAT6 sites in their endogenous conformation confers potent (up to 130-fold) IL-4 inducibility on heterologous promoters. These promoter elements constitute important and sensitive IL-4-responsive transcriptional units that could be used to drive transgene expression in sites of Th2 inflammation in vivo.

Citing Articles

Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic Dermatitis.

Cevikbas F, Ward A, Veverka K BioDrugs. 2024; 38(6):821-830.

PMID: 39404994 PMC: 11530511. DOI: 10.1007/s40259-024-00685-y.


Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis.

Zhang L, Zhang W, Xu Y, Dong L, Sun Y, Jia Y Adv Ther. 2024; 41(7):2953-2965.

PMID: 38833140 DOI: 10.1007/s12325-024-02887-w.


Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis.

Wang J, White J, Sansone K, Spelman L, Sinclair R, Yang X Clin Transl Sci. 2023; 16(12):2614-2627.

PMID: 37849431 PMC: 10719461. DOI: 10.1111/cts.13656.


Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.

Yan T, Xie Y, Liu Y, Shan Y, Wu X, Wang J Front Immunol. 2023; 14:1194088.

PMID: 37575240 PMC: 10421662. DOI: 10.3389/fimmu.2023.1194088.


The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types.

Jacques C, Chatelais M, Fekir K, Brulefert A, Floris I Int J Mol Sci. 2022; 23(4).

PMID: 35216428 PMC: 8879050. DOI: 10.3390/ijms23042314.


References
1.
Vinkemeier U, Cohen S, Moarefi I, Chait B, Kuriyan J, Darnell Jr J . DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 1996; 15(20):5616-26. PMC: 452306. View

2.
Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O . The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997; 272(23):15036-42. DOI: 10.1074/jbc.272.23.15036. View

3.
Meyer W, Reichenbach P, Schindler U, Soldaini E, Nabholz M . Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J Biol Chem. 1998; 272(50):31821-8. DOI: 10.1074/jbc.272.50.31821. View

4.
Gorski K, Shin T, Crafton E, Otsuji M, Rattis F, Huang X . A set of genes selectively expressed in murine dendritic cells: utility of related cis-acting sequences for lentiviral gene transfer. Mol Immunol. 2003; 40(1):35-47. DOI: 10.1016/s0161-5890(03)00085-3. View

5.
Mueller T, Zhang J, Sebald W, Duschl A . Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta. 2002; 1592(3):237-50. DOI: 10.1016/s0167-4889(02)00318-x. View